Passage Bio - 53 Year Dividend History | PASG
Historical dividend payout and yield for Passage Bio (PASG) since 1971. The current TTM dividend payout for Passage Bio (PASG) as of November 19, 2024 is $0.00. The current dividend yield for Passage Bio as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.030B |
$0.000B |
|
Passage Bio Inc. is a genetic medicines company. It is focused on developing transformative therapies for rare, monogenic central nervous system diseases. The company's principal product includes GM1 gangliosidosis, frontotemporal dementia and Krabbe disease which is in clinical stage. Passage Bio Inc. is based in Philadelphia, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
